Ob/Gyn Articles

Ob/Gyn

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Hide M et al. – Trastuzumab and paclitaxel–combination with the assessment of central nervous system lesions should be considered as an option for the treatment of HER2–positive EMPD.

Related Articles

Extramammary Perianal Paget's Disease
Case Reports in Gastroenterology, 11/24/09    Relevance Score: 67%%

Paget's disease of bone
Expert Review of Endocrinology & Metabolism, 11/10/09    Relevance Score: 66%%

Recent advances in understanding the molecular basis of Paget's disease of bone
Journal of Clinical Pathology, 11/10/09    Relevance Score: 66%%

Serum homocysteine, folate and vitamin B12 in patients with Paget's disease of bone: the effect of zoledronic acid
Journal of Bone and Mineral Metabolism, 11/09/09    Relevance Score: 64%%

Prognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: An institutional-based review
Journal of Clinical Oncology, 11/30/09    Relevance Score: 47%%

Today in Clinical Pharmacology...keeping you current

Endometrial Cancer in Postmenopausal Women Using Estradiol-Progestin Therapy
Obstetrics and Gynecology, 12/01/09

Paracervical Block With Combined Ketorolac and Lidocaine in First-Trimester Surgical Abortion
Obstetrics and Gynecology, 12/01/09

Effect of methylphenidate on fatigue in women with recurrent gynecologic cancer
Psycho-Oncology, 12/01/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address